Anthony Jerant1, Richard Kravitz, Monique Moore-Hill, Peter Franks. 1. Department of Family and Community Medicine, University of California Davis School of Medicine (UCDSOM), 4860 Y Street, Suite 2300, Sacramento, CA 95817, USA. afjerant@ucdavis.edu
Abstract
BACKGROUND: Identifying moderators of the effects of self-efficacy enhancing interventions could facilitate their refinement and more targeted, cost-effective delivery. Current theories and data concerning the potential moderating effect of depressive symptoms on interventions to enhance patient chronic illness self-management self-efficacy are conflicting. OBJECTIVES: To explore the moderating effect of depressive symptoms on the effect of an intervention to enhance patient self-efficacy for self-managing chronic illness. RESEARCH DESIGN: Regression analyses using baseline and postintervention (6 weeks) data from an ongoing randomized controlled trial. SUBJECTS:Patients (N = 415) aged >or=40 years recruited from a primary care network in Northern California with arthritis, asthma, chronic obstructive pulmonary disease, congestive heart failure, depression, and/or diabetes mellitus, plus impairment in >or=1 basic activity, and/or a score of >or=4 on the 10-item Center for Epidemiologic Studies Depression Scale (CES-D). MEASURES: Stanford self-efficacy scale, self-reported depression, CES-D, and Medical Outcomes Study Short Form health status questionnaire (SF-36) Mental Component Summary score. RESULTS: Regression analyses revealed the intervention was effective primarily in those with self-reported depression (interaction effect F = 8.24, P = 0.0003), highest CES-D score category (F = 5.68, P = 0.0037), and lowest (most depressed) Mental Component Summary-36 tercile (F = 4.36, P = 0.0135). CONCLUSIONS: Individuals with more depressive symptoms seem more likely to experience self-efficacy gains from chronic illness self-management training than individuals with less depressive symptoms. Future self-management training studies should stratify subjects within study groups by depressive symptom level to further explore its potential moderating effect.
RCT Entities:
BACKGROUND: Identifying moderators of the effects of self-efficacy enhancing interventions could facilitate their refinement and more targeted, cost-effective delivery. Current theories and data concerning the potential moderating effect of depressive symptoms on interventions to enhance patient chronic illness self-management self-efficacy are conflicting. OBJECTIVES: To explore the moderating effect of depressive symptoms on the effect of an intervention to enhance patient self-efficacy for self-managing chronic illness. RESEARCH DESIGN: Regression analyses using baseline and postintervention (6 weeks) data from an ongoing randomized controlled trial. SUBJECTS:Patients (N = 415) aged >or=40 years recruited from a primary care network in Northern California with arthritis, asthma, chronic obstructive pulmonary disease, congestive heart failure, depression, and/or diabetes mellitus, plus impairment in >or=1 basic activity, and/or a score of >or=4 on the 10-item Center for Epidemiologic Studies Depression Scale (CES-D). MEASURES: Stanford self-efficacy scale, self-reported depression, CES-D, and Medical Outcomes Study Short Form health status questionnaire (SF-36) Mental Component Summary score. RESULTS: Regression analyses revealed the intervention was effective primarily in those with self-reported depression (interaction effect F = 8.24, P = 0.0003), highest CES-D score category (F = 5.68, P = 0.0037), and lowest (most depressed) Mental Component Summary-36 tercile (F = 4.36, P = 0.0135). CONCLUSIONS: Individuals with more depressive symptoms seem more likely to experience self-efficacy gains from chronic illness self-management training than individuals with less depressive symptoms. Future self-management training studies should stratify subjects within study groups by depressive symptom level to further explore its potential moderating effect.
Authors: S Martin; M C Roderick; R Lockridge; M A Toledo-Tamula; A Baldwin; P Knight; P Wolters Journal: J Genet Couns Date: 2016-11-07 Impact factor: 2.537
Authors: Joseph J Gallo; Seungyoung Hwang; Jin Hui Joo; Hillary R Bogner; Knashawn H Morales; Martha L Bruce; Charles F Reynolds Journal: J Gen Intern Med Date: 2015-10-02 Impact factor: 5.128
Authors: Anthony Jerant; Brent Hanson; Richard L Kravitz; Daniel J Tancredi; Emily Hanes; Sanjeet Grewal; Rimaben Cabrera; Peter Franks Journal: Patient Educ Couns Date: 2016-08-22
Authors: Anthony Jerant; Richard L Kravitz; Daniel Tancredi; Debora A Paterniti; Lynda White; Lynn Baker-Nauman; Dionne Evans-Dean; Chloe Villarreal; Lori Ried; Andrew Hudnut; Peter Franks Journal: J Gen Intern Med Date: 2016-03-08 Impact factor: 5.128
Authors: Anthony Jerant; Melissa Lichte; Richard L Kravitz; Daniel J Tancredi; Elizabeth M Magnan; Andrew Hudnut; Peter Franks Journal: Patient Educ Couns Date: 2016-07-02
Authors: Lawrence Fisher; Joseph T Mullan; Patricia Arean; Russell E Glasgow; Danielle Hessler; Umesh Masharani Journal: Diabetes Care Date: 2009-10-16 Impact factor: 19.112